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Cardiovascular disease (CVD) is the leading cause of death worldwide and it exhibits a greatly increasing
incidence proportional to aging. Atherosclerosis is a chronic condition of arterial hardening resulting in
restriction of oxygen delivery and blood ﬂow to the heart. Relationships between mitochondrial DNA
damage, oxidant production, and early atherogenesis have been recently established and it is likely that
aspects of atherosclerotic risk are metabolic in nature. Here we present a novel method through which
mitochondrial bioenergetics can be assessed from whole aorta tissue. This method does not require
mitochondrial isolation or cell culture and it allows for multiple technical replicates and expedient
measurement. This procedure facilitates quantitative bioenergetic analysis and can provide great utility
in better understanding the link between mitochondria, metabolism, and atherogenesis.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Introduction
Cardiovascular disease (CVD) is the leading cause of death
worldwide, and nearly 600,000 deaths were caused by CVD in the
United States alone in 2010 [1–3]. Though mortality due to CVD
has declined in recent years in high-income countries, incidence
has held steady or even increased in many middle and low income
countries [4]. CVD mortality exhibits an exponential increase
proportional to age and is seen more often in men than in women
[4]. Primary prevention strategies, improved treatment options,
and policy changes related to addressing risk factors (e.g. reducing
tobacco smoke use and exposure) have all contributed to the
encouraging trend of diminished CVD related mortality in higher
income countries [5]. Part of the problem in adequately managing
CVD is that acute myocardial events are often the result of years of
asymptomatic disease progression [6]. In view of this, an improved
understanding of the processes that contribute to CVD may
signiﬁcantly contribute to additional treatment options or more
precise preventative care.
Atherosclerosis is a chronic condition where the innermost
layer of the artery becomes hardened and narrowed due to a
buildup of plaque [7]. Damaged arterial endothelium accumulates
LDL cholesterol and blood-borne monocytes which leads to further
inﬂammation and biochemical modiﬁcations [8,9]. The athero-
sclerotic plaque then begins to clog the artery, making blood ﬂowB.V. This is an open access article
outh, Birmingham, AL 35294-
.and oxygen delivery difﬁcult. If the artery becomes fully occluded,
irreversible myocardial cell damage or cell death will occur [7].
Though coronary plaque growth may remain stable for many
years, it is also possible for plaques to suddenly rupture, leading
to immediate downstream intraluminal thrombi and accelerated
blood-ﬂow obstruction resulting in myocardial infarction [10,11].
High blood pressure, high cholesterol, diabetes, obesity, smoking,
and a family history of heart disease are all risk factors for
atherosclerosis in addition to aging [3,12,13].
Reactive oxygen species (ROS) are chemically reactive mole-
cules formed as a byproduct of oxidative metabolism which serve
important roles in homeostasis and cell signaling as well as
increasingly appreciated functions in various pathologies [14–16].
Epidemiological studies support an association between increased
ROS levels and common CVD risk factors [17,18]. More recently,
mitochondrial function and reactive species production have also
been implicated in atherogenesis [19,20]. Exposure of vascular
cells to ROS results in mitochondrial DNA (mtDNA) damage and
dysfunction which negatively affects the metabolic phenotype,
subsequently resulting in endothelial cell dysfunction and smooth
muscle cell disturbances [21]. The idea that mtDNA damage
accumulation is an initiating event in atherogenesis is additionally
consistent and complementary with popular inﬂammatory re-
sponse theories [7,22,23]. Previously, assays directed toward
determining the extent of mtDNA damage were used to investigate
early atherogenesis [20]. Using that approach is a helpful way to
characterize damaged mtDNA, but a more complete and quanti-
tative picture may yet be obtained.under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
Fig. 1. Example experimental trace result from the XF24 depicting oxygen
consumption rate (OCR) of an ex-vivo aortic ring in response to a sequence of
metabolic effectors. Following measurement of baseline oxygen consumption,
oligomycin is added to inhibit ATP synthase which initiates a decline in oxygen
consumption, thus delineating between oxygen consumption that is linked (ATP-
linked) or not linked to ATP production (non-ATP). FCCP is a mitochondrial
uncoupling agent which facilitates maximal oxygen consumption, while antimycin
A is a potent inhibitor of electron transport complexes III. The difference between
the maximal OCR following FCCP and the baseline OCR is the reserve capacity.
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consumption and extracellular acidiﬁcation to be measured from
tissue in response to speciﬁc electron transport chain effectors in
real time [24]. By doing this, bioenergetic proﬁles can be generated
that further enable investigation into the role of metabolic
differences on cardiovascular disease susceptibility and progres-
sion. ATP-linked respiration, maximal respiration, reserve capacity,
and non-mitochondrial oxygen consumption are all parameters
that can be measured over a single experiment in addition to
baseline respiration (Fig. 1) [24,25]. Herein, we present an assay
enabling generation of bioenergetic proﬁles using an ex vivo
method from isolated aortic sections taken from apolipoprotein
E null (apoE /) mice fed either a chow diet or a western high fat
diet. ApoE is a lipoprotein receptor ligand responsible for LDL
uptake that, when missing, as in the apoE mouse, leads to elevated
serum LDL cholesterol levels and atherosclerotic lesion develop-
ment [26,27].Methods
All procedures and manipulations of animals were approved by
the Institutional Animal Care and Use Committee (IACUC) of the
University of Alabama at Birmingham in accordance with the
United States Public Health Service Policy on the humane Care
and Use of Animals, and the NIH Guide for the Care and Use of
Laboratory Animals.Fig. 2. Images depicting an isolated aorta (A) beSeahorse XF24 preparation
1.0 mL of Seahorse Bioscience XF24 Calibrant pH 7.4 (#100840-
000, Seahorse Bioscience, North Billerica, MA) was added to each
well of a Seahorse Bioscience 24-well plate (#100777-004) that is
kept overnight at room temperature.
Mice
C57BL/6J apoE / male mice (002052) were purchased from
Jackson Laboratories in Bar Harbor, Maine. All mice were fed chow
diets (4% fat: Harlan Teklad diet 7001) until 6 weeks old when half
remained on chow and the other half were fed a western high fat
diet (21% fat: Harlan Teklad diet 88137) for 10 weeks until sacriﬁce
at 16 weeks. Four mice, two from each diet group, were sacriﬁced
on the same day for aorta removal and Seahorse plate preparation.
Aortic isolation
Mice were sacriﬁced at 16 weeks of age via prolonged exposure to
a dose of isoﬂurane followed by cervical dislocation. The aorta was
removed and placed into a 10020 mm2 cell culture dish containing
1 mL of unbuffered DMEM. Under a dissecting microscope, exterior
fat and extraneous branching arteries were carefully removed (Fig. 2).
Next, the aorta was cleaned, opened longitudinally, and cut into
equal pieces 3 mm in length (in this manner, the typical aorta
provides 4 pieces).
Seahorse XF-24 protocol
Aortic sections were placed into individual wells on an XF24
cell culture plate pre-warmed with unbuffered DMEM (250 mL,
37 °C), leaving appropriate temperature correction wells blank
(A1, B4, C3, D6). Tissue was incubated in the XF24 cell culture
plate in a 37 °C incubator without CO2 until ready for use to allow
aortic sections to equilibrate to the new media. Injection com-
pound dilutions were made in appropriate running media
(unbuffered DMEM) for the bioenergetic proﬁle analysis experi-
ment. Initially, titration experiments were run to determine
each effector’s appropriate working concentration. For these
studies, optimal concentrations were found to be: 10 mg/mL
Oligomycin, 1 mM FCCP (Triﬂuorocarbonylcyanide Phenylhydra-
zone), and 10 mM Antimycin A.
Oligomycin, FCCP, Antimycin A, and media were loaded into
injection ports A, B, C, and D, respectively, in 75 mL volumes for
each experimental well. All wells, including temperature correc-
tion wells, had control media or compounds loaded into all ports
to ensure uniform injection. Once prepared, the plate containing
the effectors was placed atop the plate containing the aorta
samples and placed into the XF24 Bioanalyzer. Each oxygen
consumption rate (OCR) measurement consisted of 3 min offore and (B) after removing extraneous fat.
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measurement. There were 3 measurement rounds per injection.
Data analysis and interpretation
The Seahorse XF-24 outputs experimental data as a connected
scatter plot with either Oxygen Consumption Rate (OCR) or
Extracellular Acidiﬁcation Rate (ECAR) on the y-axis and time on
the x-axis. Once converted into a table format, the data from each
sample was divided into four blocks corresponding to each effector
injection: basal, oligomycin, FCCP, and antimycin-A. The relevant
measures for each block was as follows: basal average, oligomycin
minimum, FCCP maximum, and antimycin-A minimum. These
values were used to determine the OCRs at baseline, linked to
ATP, not linked to ATP (non-ATP), at maximal levels, and the
reserve capacity. ATP-linked oxygen consumption was determined
by ﬁnding the difference between the baseline OCR and the post-
oligomycin minimum OCR; the value of the post-oligomycin
minimum represents the OCR not linked to ATP generation (non-
ATP). The maximum OCR is determined from the maximum value
of post-FCCP OCR. Lastly, reserve capacity was the difference
between the baseline and maximum OCRs.
Variation between individual Seahorse wells containing pieces
of the same aorta is present in these experiments. For these
studies the coefﬁcient of variation (CV) had a range from 0.06 to
0.7, with an average of 0.2. This compares quite favorably to a
recent ex vivo method for using adipose tissues published by our
group [28].Results
This report details the development of an assay that enables
real-time quantiﬁcation of oxygen utilization and extracellular
acidiﬁcation from ex-vivo aortic slices. In preliminary analyzes
comparing bioenergetic proﬁles between apoE / mice that were
either fed a standard chow diet or a western high fat diet, the mice
on high fat diet had a higher basal OCR than their chow-fed
counterparts (Fig. 3). The component parts of these different
baseline measures are also different. The chow-fed animals have
a baseline OCR that is 32% ATP-linked and 68% non-ATP-linked
whereas the HFD-fed animals have a baseline OCR that is 41% ATP-
linked and 59% non-ATP-linked (Fig. 4). Further dissection of
changes in bioenergetics capacities suggested that changes in0
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Fig. 3. Oxygen consumption rates in ex-vivo aortic sections taken from 16-week
old apoE / mice fed either chow or a high fat diet. Traces are from a single
experiment using 2 mice per group with 4 replicates per mouse (i.e. 4 aortic
sections per mouse). OCR is measured under basal conditions as well as following
addition of oligiomycin, FCCP, and antimycin A. Each data point is the average of
four independent measurements. Error bars indicate 7S.E.M.“reserve capacity” occurred between chow and high fat diet
groups (Fig. 4). Reserve capacity is a measure of the difference
between the maximum possible OCR (following FCCP addition)
and the baseline OCR. This parameter is proposed to be a measure
of the ability of cells or tissue to respond to stresses by increasing
their metabolic output. When incorporating this parameter into
the observed bioenergetics it revealed that under maximal oxygen
consumption rates (FCCP induced), reserve capacity accounted for
60% and 56% of the maximum OCR for chow and high fat diet
animals, respectively, and oxygen utilization for ATP generation to
be 13% and 18% in chow and high fat groups, respectively (Fig. 4).Discussion and conclusions
Given that cardiovascular disease is the leading cause of death
worldwide in both men and in women, the need to better
investigate and understand mechanisms of atherosclerosis is a
priority in the medical research world. The purpose of this study
was to develop a robust, efﬁcient, and reproducible method for
evaluating tissue bioenergetics from ex-vivo aorta. Such an assay
could then be used to directly observe the metabolic phenotype of
aortic sections, thus allowing for a wide range of experimental
designs directed toward deepening our understanding of the role
of metabolism in cardiovascular disease risk and progression.
An important point when considering normalizing these ex-
perimental data is that equally sized aortic slices may not contain
the same amount of mitochondria. This is especially true in the
case of comparing healthy to diseased aortas, or when comparing
the bioenergetics of aortas taken from mice on different genetic
backgrounds. While differences in mitochondrial numbers are
normalized when determining relative percent OCR dedicated
for ATP, non-ATP, and reserve capacity, when reporting actual
OCR, it can be necessary to normalize all bioenergetic data against
mtDNA copy number. This can be done via quantiﬁcation of
mtDNA copy numbers, described previously [29].
The observed changes in bioenergetics in aortic ring tissues
collected from chow and high fat diet fed mice represent a
categorical “mean” of that tissue. While tissue orientation is
endothelial “side-up” for this method, OCR could be affected by
additional associated cells linked to disease pathology such as
macrophage and proliferating smooth muscle cells. In this respect,
qualitatively determining thresholds for healthy and unhealthy
aorta would be disease-model speciﬁc. For concerns regarding
attributing differences in bioenergetics to speciﬁc cell types, OCR
data could be normalized against cell speciﬁc markers. Alterna-
tively, primary cells could be isolated; however this approach
precludes ex vivo measures, and also has drawbacks of cell ﬁtness
and selection during culture expansion. Using this ex vivo ap-
proach, we show that high fat diet feeding in apoE/ mice
decreases reserve capacity and increases OCR for ATP production
in aortic rings, compared to chow fed apoE / . To further
delineate interpretation, mitochondrial DNA damage analysis
could be performed post hoc on the same tissue samples to assess
both mtDNA damage and total mitochondrial number (as men-
tioned previously) in the tissue, as well as total DNA content to
estimate cellularity, and as previously suggested, cell speciﬁc
markers to determine relative ratios of cell types.
This method is distinct from previously published strategies
designed to investigate potential links between oxidative damage,
metabolic phenotype, and atherosclerotic risk in that there is no
need for mitochondrial isolation or cell culture using the ex vivo
method, and this technique can be performed quickly and repro-
ducibly. Furthermore, directly measuring bioenergetics from
primary aortic tissues precludes complications that arise from
unnecessary additional sample manipulation. Having several
Fig. 4. Pie charts indicating oxygen utilization proﬁles of aortic sections for chow and high-fat fed apoE / mice from 4 individual experiments. The left side displays the
percentage of basal oxygen consumption that is linked to ATP production and non-ATP production for chow (A) and high fat fed (B) animals. The right side displays the
percentage of maximal oxygen consumption that is linked to reserve capacity, ATP production, or non-ATP production for chow (C) and high fat fed (D) animals.
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analyzed simultaneously provides the beneﬁt of addressing any
potential experimental variation. Beyond its utility in examining
mouse aorta, this ex-vivo bioenergetic approach could be ex-
tended for use in vascular biopsies taken from surgical specimens,
or even in a prophylactic setting to improve diagnostics. As
suggested in these studies, we would anticipate decreased reserve
capacity with pathology progression, often associated with in-
creased oxygen consumption under basal conditions.Acknowledgements
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